Literature DB >> 20331811

Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS.

Francesca Tentori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20331811     DOI： 10.1111/j.1525-139X.2009.00676.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  9 in total

1.  Dialysis: Nocturnal hemodialysis--should we still provide this therapy?

Authors:  Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2011-09-20       Impact factor: 28.314

Review 2.  Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Authors:  David J A Goldsmith; John Cunningham
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

3.  Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism.

Authors:  Yue Yu; Zongli Diao; Ying Wang; Peiyi Zhou; Rui Ding; Wenhu Liu
Journal:  Ther Adv Endocrinol Metab       Date:  2020-09-21       Impact factor: 3.565

4.  Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function.

Authors:  Mengjing Wang; Li You; Haiming Li; Yong Lin; Zhijie Zhang; Chuanming Hao; Jing Chen
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 8.237

5.  Mineral and bone disorder in Chinese dialysis patients: a multicenter study.

Authors:  Xianglei Kong; Luxia Zhang; Ling Zhang; Nan Chen; Yong Gu; Xueqing Yu; Wenhu Liu; Jianghua Chen; Liren Peng; Weijie Yuan; Hua Wu; Wei Chen; Minhua Fan; Liqun He; Feng Ding; Xiangmei Chen; Zuying Xiong; Jinyuan Zhang; Qiang Jia; Wei Shi; Changying Xing; Xiaoling Tang; Fanfan Hou; Guiyang Shu; Changlin Mei; Li Wang; Dongmei Xu; Zhaohui Ni; Li Zuo; Mei Wang; Haiyan Wang
Journal:  BMC Nephrol       Date:  2012-09-21       Impact factor: 2.388

6.  Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.

Authors:  Meghan J Elliott; Sarah L Booth; Wilma M Hopman; Rachel M Holden
Journal:  Can J Kidney Health Dis       Date:  2014-06-24

7.  Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China.

Authors:  Ying-Ping Sun; Wen-Jun Yang; Su-Hua Li; Yuan-Yuan Han; Jian Liu
Journal:  Biomed Res Int       Date:  2017-02-19       Impact factor: 3.411

8.  Prevalence of Chronic Kidney Disease-Mineral Bone Disorder in Hemodialysis Patients in Hebei, China.

Authors:  Jing-Jing Jin; Sheng-Lei Zhang; Jin-Sheng Xu; Li-Wen Cui; Hui-Ran Zhang; Ya-Ling Bai
Journal:  Chin Med J (Engl)       Date:  2018-11-20       Impact factor: 2.628

9.  Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.

Authors:  Zong-Hui Dang; Chen Tang; Guo-Liang Li; Ciren Luobu; Zhen-Hua Ma; Jing-Feng Qu; Lamu Suolang; Li-Jun Liu
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.